Reports
Europe COVID-19 Diagnostics Market: By Test Type: PCR Test, Antigen Test, Antibody Test, Others; By Product: RT-PCR Assay Kits, Immunoassay Test Strips, Others; By Sample Type; By Business Model; By End Use: Hospitals, Diagnostic Centres and Clinics, Laboratories, Others; By Country (2020-2026); Competitive Landscape, 2023-2028
Europe COVID-19 Diagnostics Market Outlook
The Europe COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the UK and France, which have performed around 112 million and 58 million tests, respectively, for COVID-19 as of March 2021.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Favourable Government Policies to Aid the Market Growth of COVID-19 Diagnostics
The rising cases of COVID-19 have boosted the funding from government and private institutions for R&D in the field. Further, the rising number of emergency use authorizations for diagnostic kits & products, and advances and sponsorship from non-medical device or diagnostic firms have been projected to affect the global COVID-19 diagnostics industry positively. Many of the leading manufacturers of COVID-19 diagnostics are from European countries such as Germany and Italy. The development of various effective tests is expected to help the market growth over the coming years.
COVID-19 Diagnostics: Market Segmentation
COVID-19 diagnostics are standardized equipment used for the detection and diagnosis of Covid-19. These are manufactured by approved pharmaceutical manufacturers under strict government procedures.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By test type, the market is divided into:
- PCR Test
- Antigen Test
- Antibody Test
- Others
The market is categorised in terms of product into:
- RT-PCR Assay Kits
- Immunoassay Test Strips
- Others
The market is divided on the basis of sample type into:
- Nasopharyngeal Swab
- Oropharyngeal (OP) Swab
- Nasal Swab
- Blood Test
- Others
On the basis of business model, the industry is bifurcated into:
- Point-of-Care (PoC) Testing
- Non-Point-of-Care (PoC) Testing
In terms of end use, the market is segmented into:
- Hospitals
- Diagnostic Centres and Clinics
- Laboratories
- Others
The EMR report looks into the regional markets of the product like Germany, Italy, the UK, France, and rest of Europe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rise in Government Funding to Boost the Market Growth of COVID-19 Diagnostics in Europe
Increased government spending and a rising range of strategic partnerships drive the industry for COVID-19 diagnostics in Europe. Furthermore, increased federal spending is expected to fuel business demand, consequently aiding the market growth. In the forecast period, molecular (PCR) testing is expected to lead the industry. The PCR technique is actually believed to be the most effective for detecting COVID-19, resulting in a significant rise in the use of PCR research kits. This is well supported by governments across Europe which are also preparing for a mass vaccination campaign. The laboratories section is projected to produce the greatest demand.
However, due to the already in place vaccination drive started in countries such as UK, the market for COVID-19 diagnostics is also expected to witness a steep decline in the forecast period, which shall be the overriding market trend for this industry. The sharp decline is expected to end in a near fade-out of this market by the end of the forecast period due to vaccination of the global population.
Key Industry Players in the Europe COVID-19 Diagnostics Market
The report gives a detailed analysis of the following key players in the Europe COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Altona Diagnostics GmbH
- Genomica S.A.U
- Clonit srl
- BioMaxima SA
- Primerdesign Ltd
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Test Type, Product, Sample Type, Business Model, End Use, Country |
| Breakup by Test Type | PCR Test, Antigen Test, Antibody Test, Others |
| Breakup by Product | RT-PCR Assay Kits, Immunoassay Test Strips, Others |
| Breakup by Sample Type | Nasopharyngeal, SwabOropharyngeal (OP) Swab, Nasal Swab, Blood Test, Others |
| Breakup by Business Model | Point-of-Care (PoC) Testing, Non-Point-of-Care (PoC) Testing |
| Breakup by End Use | Hospitals, Diagnostic Centres and Clinics, Laboratories, Others |
| Breakup by Country | United Kingdom, Germany, Italy, France, Spain, Others |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Altona Diagnostics GmbH, Genomica S.A.U, Clonit srl, BioMaxima SA, Primerdesign Ltd, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Europe
7 Industry Opportunities and Challenges
8 Europe COVID-19 Overview
8.1 Number of COVID-19 Cases in Europe
8.2 Europe COVID-19 Cases by Country
8.2.1 United Kingdom
8.2.2 Germany
8.2.3 Italy
8.2.4 France
8.2.5 Spain
8.2.6 Others
9 Europe COVID-19 Diagnostics Market Analysis
9.1 Key Industry Highlights
9.2 Europe COVID-19 Diagnostics Market (2020-2026)
9.3 Europe COVID-19 Diagnostics Market by Test Type (2020-2026)
9.3.1 PCR Test
9.3.2 Antigen Test
9.3.3 Antibody Test
9.3.4 Others
9.4 Europe COVID-19 Diagnostics Market by Product (2020-2026)
9.4.1 RT-PCR Assay Kits
9.4.2 Immunoassay Test Strips
9.4.3 Others
9.5 Europe COVID-19 Diagnostics Market by Sample Type (2020-2026)
9.5.1 Nasopharyngeal Swab
9.5.2 Oropharyngeal (OP) Swab
9.5.3 Nasal Swab
9.5.4 Blood Test
9.5.5 Others
9.6 Europe COVID-19 Diagnostics Market by Business Model (2020-2026)
9.6.1 Point-of-Care (PoC) Testing
9.6.2 Non-Point-of-Care (PoC) Testing
9.7 Europe COVID-19 Diagnostics Market by End Use (2020-2026)
9.7.1 Hospitals
9.7.2 Diagnostic Centres and Clinics
9.7.3 Laboratories
9.7.4 Others
9.8 Europe COVID-19 Diagnostics Market by Country (2020-2026)
9.8.1 United Kingdom
9.8.2 Germany
9.8.3 Italy
9.8.4 France
9.8.5 Spain
9.8.6 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Altona Diagnostics GmbH
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Genomica S.A.U
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Clonit srl
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 BioMaxima SA
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Primerdesign Ltd
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Europe COVID-19 Cases by Country
2. Europe COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
3. Europe COVID-19 Diagnostics Market: Breakup by Test Type (USD Billion)
4. Europe COVID-19 Diagnostics Market: Breakup by Product (USD Billion)
5. Europe COVID-19 Diagnostics Market: Breakup by Sample Type (USD Billion)
6. Europe COVID-19 Diagnostics Market: Breakup by Business Model (USD Billion)
7. Europe COVID-19 Diagnostics Market: Breakup by End Use (USD Billion)
8. Europe COVID-19 Diagnostics Market: Breakup by Country (USD Billion),
9. Europe COVID-19 Diagnostics Market Structure
Key Questions Answered in the Report
The Europe COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the UK and France, which have performed around 112 million and 58 million tests, respectively, for COVID-19 as of March 2021.
The major drivers of the industry such as rising research and development, rising cases of COVID-19, and favourable government policies, are aiding the market growth.
The key market trend guiding the growth of the industry includes the technological advancements.
The major regions in the industry are Germany, Italy, the UK, France, and rest of Europe.
The major test types available in the industry are PCR test, antigen test, and antibody test, among others.
The major products available in the industry are RT-PCR assay kits, and immunoassay test strips, among others.
The sample types available in the market are nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others.
The significant business modes are point-of-care (PoC) testing and non-point-of-care (PoC) testing.
The significant end use sectors are hospitals, diagnostic centres and clinics, and laboratories, among others.
The major players in the industry are Altona Diagnostics GmbH, Genomica S.A.U, Clonit srl, BioMaxima SA, and Primerdesign Ltd, among others.
Analyst Review
The Europe COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the UK and France, which have performed around 112 million and 58 million tests, respectively, for COVID-19 as of March 2021. The market is aided by favourable government policies and rise in funding for R&D in this field.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its test types, the COVID-19 diagnostics industry can be segmented into PCR test, antigen test, and antibody test, among others. On the basis of products, the industry is divided into RT-PCR assay kits, and immunoassay test strips, among others. By sample types, the industry is categorised into nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others. On the basis of business modes, the industry is segmented into point-of-care (PoC) testing and non-point-of-care (PoC) testing. Based on end use sectors, the industry is segregated into hospitals, diagnostic centres and clinics, and laboratories, among others. The major regional markets for COVID-19 diagnostics in Europe are Germany, Italy, the UK, France, and rest of Europe. The key players in the above market include Altona Diagnostics GmbH, Genomica S.A.U, Clonit srl, BioMaxima SA, and Primerdesign Ltd, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER